Dr.Finance S.A. (WSE:DRF)
0.500
-0.095 (-15.97%)
Mar 7, 2025, 9:00 AM CET
Dr.Finance Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 10.25 | 6.22 | 7.46 | 11.74 | 7.72 | Upgrade
|
Revenue Growth (YoY) | 64.76% | -16.60% | -36.45% | 52.02% | 7.53% | Upgrade
|
Cost of Revenue | 0.43 | 0.26 | 0.33 | 0.48 | 0.38 | Upgrade
|
Gross Profit | 9.82 | 5.96 | 7.13 | 11.26 | 7.34 | Upgrade
|
Selling, General & Admin | 9.95 | 5.94 | 7.24 | 10.98 | 7.26 | Upgrade
|
Other Operating Expenses | 0.06 | 0.03 | 0.07 | 0.08 | 0.07 | Upgrade
|
Operating Expenses | 10.01 | 5.97 | 7.32 | 11.07 | 7.34 | Upgrade
|
Operating Income | -0.19 | -0.01 | -0.19 | 0.19 | 0 | Upgrade
|
Interest Expense | -0 | -0 | -0 | -0 | -0 | Upgrade
|
Interest & Investment Income | 0 | 0 | 0 | 0 | - | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | -0 | -0.01 | -0.03 | Upgrade
|
EBT Excluding Unusual Items | -0.19 | -0.01 | -0.2 | 0.19 | -0.03 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.06 | - | - | 0.01 | 0.01 | Upgrade
|
Asset Writedown | - | - | - | - | 0.01 | Upgrade
|
Other Unusual Items | - | - | - | 0 | - | Upgrade
|
Pretax Income | -0.25 | -0.01 | -0.2 | 0.2 | -0.01 | Upgrade
|
Income Tax Expense | - | - | - | 0.05 | 0.01 | Upgrade
|
Net Income | -0.25 | -0.01 | -0.2 | 0.15 | -0.01 | Upgrade
|
Net Income to Common | -0.25 | -0.01 | -0.2 | 0.15 | -0.01 | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
EPS (Basic) | -0.07 | -0.00 | -0.05 | 0.04 | -0.00 | Upgrade
|
EPS (Diluted) | -0.07 | -0.00 | -0.05 | 0.04 | -0.00 | Upgrade
|
Free Cash Flow | 0.05 | -0.19 | -0.19 | 0.05 | -0 | Upgrade
|
Free Cash Flow Per Share | 0.01 | -0.05 | -0.05 | 0.01 | -0.00 | Upgrade
|
Gross Margin | 95.77% | 95.83% | 95.56% | 95.94% | 95.06% | Upgrade
|
Operating Margin | -1.86% | -0.10% | -2.60% | 1.66% | 0.02% | Upgrade
|
Profit Margin | -2.48% | -0.12% | -2.67% | 1.27% | -0.18% | Upgrade
|
Free Cash Flow Margin | 0.51% | -3.00% | -2.49% | 0.41% | -0.02% | Upgrade
|
EBITDA | -0.19 | -0 | -0.19 | 0.2 | 0.01 | Upgrade
|
EBITDA Margin | -1.84% | -0.03% | -2.52% | 1.72% | 0.12% | Upgrade
|
D&A For EBITDA | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
EBIT | -0.19 | -0.01 | -0.19 | 0.19 | 0 | Upgrade
|
EBIT Margin | -1.86% | -0.10% | -2.60% | 1.66% | 0.02% | Upgrade
|
Effective Tax Rate | - | - | - | 24.54% | - | Upgrade
|
Revenue as Reported | 10.25 | 6.22 | 7.46 | 11.74 | 7.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.